AA Testing Page – UME Health

Request an appointment from UME Health

Your Details

Title *

First Name *

Last Name *

Contact Details

Email *

Phone

Reason for visit

Select a service

Appointment type

What would you like to discuss in your consultation?

Marketing preferences

I consent to my personal data being used for information to be sent to me, which is relevant to me and/or my treatment. For further information on how your data is used, read our Privacy Policy.

CaRi-Heart® Technology by Caristo Diagnostics

UME Health Harley Street offers revolutionary new technology to assess the risk of a serious heart condition or heart attack - many years before anything happens.

The absolute risk of a fatal cardiac event within the next 8 years based on personalized FAI- score values, the coronary atherosclerotic plaque burden and clinical risk factors
Provides prognostic information on future CV risks to facilitate personalized prevention
The patient's relative risk of a fatal cardiac event, compared with people of the same age and general, based on the qualification of coronary inflammation (FAI-score)

Book now

Call us

MYOSTRAIN - Novel Software Informatics to Transform Cardiac Care

MyoStrain is a first-of-its-kind proprietary 10-minute, quantitative heart health assessment that provides physicians with visibility into the subtle changes of myocardial function. Utilizing segmental intra-myocardial strain, MyoStrain helps physicians rapidly predict, detect and manage the early progression of heart dysfunction before symptoms occur to proactively prevent adverse events.

"MyoStrain is a promising technology to help ensure cardiac health in patients receiving potentially cardio- toxic cancer therapies."

Lauren Baldassarre, MD

Cardiologist, Associate Professor at Yale School of Medicine

Learn more

Single-use cardiac monitoring powered by Al technology

iRhythm is a digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining our wearable biosensing technology with cloud-based data analytics and machine-learning capabilities. Our goal is to be the leading provider of first-line ambulatory electrocardiogram, or ECG, monitoring for patients at risk for arrhythmias.

The Zio service is a complete ambulatory cardiac monitoring solution built with the patient in mind - and reinforced with clinical evidence. We have created a unique platform, ZIO by iRhythm, which we believe allows clinicians to diagnose many arrhythmias more quickly and efficiently than traditional technologies, avoiding multiple indeterminate tests, allowing for appropriate medical intervention and potentially avoiding more serious downstream medical events, including stroke (iRhythm Clinical Publication Summary).